Patent details

Basic Information

Publication number:

EP1173197

PCT Application Number:

PCT/US/2000/011251

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP009264045

PCT Publication Number:

WO/2000/066138

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METABOLIC INTERVENTION WITH GLP-1 TO IMPROVE THE FUNCTION OF ISCHEMIC AND REPERFUSED TISSUE

French Title of Invention:

INTERVENTION METABOLIQUE AU MOYEN D'UN PEPTIDE 1 DU TYPE GUCAGON (GLP-1) PERMETTANT D'AMELIORER UNE LESION D'UN TISSU PROVOQUEE PAR UNE ISCHEMIE ET UNE REPERFUSION

German Title of Invention:

METABOLISCHE INTERVENTION MIT GLP-1 ZUR VERBESSERUNG DER FUNKTION VON ISCHÄMISCHEM UND WIEDERDURCHBLUTETEM GEWEBE

SPC Number:

Dates

Filing date:

27/04/2000

Grant date:

01/12/2004

EP Publication Date:

01/12/2004

PCT Publication Date:

09/11/2000

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/01/2002

EP B1 Publication Date:

01/12/2004

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

27/04/2016

Expiration date:

27/04/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/02/2013

 

 

Name:

AMYLIN PHARMACEUTICALS, LLC

Address:

TOWNE CENTRE DRIVE, SAN DIEGO, CALIFORNIA, United States (US)

Name:

ASTRAZENECA PHARMACEUTICALS , LP

Address:

CONCORD PIKE 1800, WILMINGTON, DELAWARE, United States (US)

History of Owners

From:

27/04/2000

To:

03/02/2013

Name:

AMYLIN PHARMACEUTICALS INC.

Address:

9373 Towne Centre Drive, San Diego, California 92121, United States (US)

Agent

Name:

SPEICH STEPHANE

From:

11/02/2005

Address:

RUE DES BRUYERES 55, 1274, HOWALD, Luxembourg (LU)

To:

Inventor

1

Name:

EHLERS Mario, R., W.

Address:

United States (US)

2

Name:

COOLIDGE Thomas, R.

Address:

United States (US)

Priority

Priority Number:

302596

Priority Date:

30/04/1999

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/26;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

08/04/2015

Last Annual Fee Paid Number:

16

Last Annual Fee Paid Amount:

230 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages